These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16675572)

  • 1. Prognostic DNA methylation biomarkers in ovarian cancer.
    Wei SH; Balch C; Paik HH; Kim YS; Baldwin RL; Liyanarachchi S; Li L; Wang Z; Wan JC; Davuluri RV; Karlan BY; Gifford G; Brown R; Kim S; Huang TH; Nephew KP
    Clin Cancer Res; 2006 May; 12(9):2788-94. PubMed ID: 16675572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
    Wei SH; Chen CM; Strathdee G; Harnsomburana J; Shyu CR; Rahmatpanah F; Shi H; Ng SW; Yan PS; Nephew KP; Brown R; Huang TH
    Clin Cancer Res; 2002 Jul; 8(7):2246-52. PubMed ID: 12114427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.
    Model F; Osborn N; Ahlquist D; Gruetzmann R; Molnar B; Sipos F; Galamb O; Pilarsky C; Saeger HD; Tulassay Z; Hale K; Mooney S; Lograsso J; Adorjan P; Lesche R; Dessauer A; Kleiber J; Porstmann B; Sledziewski A; Lofton-Day C
    Mol Cancer Res; 2007 Feb; 5(2):153-63. PubMed ID: 17314273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.
    Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA
    Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic sweeping for hypermethylated genes.
    Goh L; Murphy SK; Muhkerjee S; Furey TS
    Bioinformatics; 2007 Feb; 23(3):281-8. PubMed ID: 17148511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
    Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer.
    Duncan TJ; Rolland P; Deen S; Scott IV; Liu DT; Spendlove I; Durrant LG
    Clin Cancer Res; 2007 Jul; 13(14):4139-45. PubMed ID: 17634541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence.
    de Maat MF; van de Velde CJ; van der Werff MP; Putter H; Umetani N; Klein-Kranenbarg EM; Turner RR; van Krieken JH; Bilchik A; Tollenaar RA; Hoon DS
    J Clin Oncol; 2008 May; 26(14):2327-35. PubMed ID: 18467724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis.
    Mhawech-Fauceglia P; Herrmann FR; Andrews C; South S; Beck A; Lele S; Odunsi K
    Eur J Surg Oncol; 2009 Jul; 35(7):763-7. PubMed ID: 19081223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
    Rolland P; Deen S; Scott I; Durrant L; Spendlove I
    Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
    Barton CA; Hacker NF; Clark SJ; O'Brien PM
    Gynecol Oncol; 2008 Apr; 109(1):129-39. PubMed ID: 18234305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.
    Meinhold-Heerlein I; Bauerschlag D; Zhou Y; Sapinoso LM; Ching K; Frierson H; Bräutigam K; Sehouli J; Stickeler E; Könsgen D; Hilpert F; von Kaisenberg CS; Pfisterer J; Bauknecht T; Jonat W; Arnold N; Hampton GM
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):458-66. PubMed ID: 17255266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated algorithm for gene selection and classification applied to microarray data of ovarian cancer.
    Lee ZJ
    Artif Intell Med; 2008 Jan; 42(1):81-93. PubMed ID: 18006289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers.
    Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T
    Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling studies in ovarian cancer: a review.
    Fehrmann RS; Li XY; van der Zee AG; de Jong S; Te Meerman GJ; de Vries EG; Crijns AP
    Oncologist; 2007 Aug; 12(8):960-6. PubMed ID: 17766655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.